The immune response and its therapeutic modulation in bronchiectasis

Area of Science:

• Pulmonology
• Immunology
• Pathogenesis of Lung Diseases

Background:

• Bronchiectasis (BC) is a chronic respiratory condition characterized by significant morbidity and mortality.
• Pathogen infection is a key factor in BC development, highlighting the role of the immune system.
• Immune cells and mediators are found in airways and lung tissue, with altered levels in BC patients.

Purpose of the Study:

• To re-evaluate the roles of innate and acquired immunity in bronchiectasis pathogenesis.
• To identify key sites and mediators of immune responses in BC.
• To explore the relationship between immune responses, disease progression, and therapeutic strategies.

Main Methods:

• Review and analysis of existing literature on immune responses in bronchiectasis.
• Examination of the interplay between immune cells, mediators, and structural lung changes.
• Assessment of immunomodulatory therapies in the context of BC.

Main Results:

• The immune system's role in BC can be either protective or damaging, depending on factors like patient immunity, infection severity, and response magnitude.
• Specific immune cells and mediators are implicated in the structural alterations seen in BC.
• Therapeutic strategies targeting immune modulation show potential for managing BC.

Conclusions:

• Immune response dynamics are central to bronchiectasis pathogenesis.
• Further research into immune mechanisms can guide the development of targeted therapies for BC.
• Modulating the immune response is a promising avenue for treating bronchiectasis.